Abstract
Diseases caused by viruses are a global threat, resulting in serious medical and social problems for humanity. They are the main contributors to many minor and major outbreaks, epidemics, and pandemics worldwide. Over the years, medicinal plants have been used as a complementary treatment in a range of diseases. In this sense, this review addresses promising antiviral plants from Marajó island, a part of the Amazon region, which is known to present a very wide biodiversity of medicinal plants. The present review has been limited to articles and abstracts available in Scopus, Web of Science, Science Direct, Scielo, PubMed, and Google Scholar, as well as the patent offices in Brazil (INPI), United States (USPTO), Europe (EPO) and World Intellectual Property Organization (WIPO). As a result, some plants from Marajó island were reported to have actions against HIV-1,2, HSV-1,2, SARS-CoV-2, HAV and HBV, Poliovirus, and influenza. Our major conclusion is that plants of the Marajó region show promising perspectives regarding pharmacological potential in combatting future viral diseases.
Keywords: viral diseases, plants extract, medicinal plants, Amazon region
1. Introduction
Viruses are a global threat and, in addition to health problems, cause serious social problems to humanity. They are the main contributors to many minor and major outbreaks, epidemics, and pandemics worldwide, such as swine flu, avian influenza, dengue fever, and the current SARS-CoV-2 that causes COVID-19 [1,2]. Although several treatment methods are available for viral diseases, viruses evolve rapidly and this requires a search for new potent and effective antiviral compounds with fewer or, better yet, no adverse side effects at all [1].
Medicinal plants have been documented as a means of complementary treatments that are useful for a range of diseases. However, few have been applied to the treatment of viral diseases. This is because some viral targets have very specific interactions with with natural molecules. Furthermore, most antivirals that are used as drugs show undesirable side effects, or the virus ends up developing a resistance to the drug, as well as recurrence and latency. In this sense, many medicinal plants can be candidates for the discovery of new antivirals due to their strong antiviral activity, fewer side effects, and the capacity to inhibit the replication or synthesis of some virus genome [3]. In addition, science has already proved the safer benefits of herbal medicines and also supports the idea of improved therapy when these herbal medicines are used in combination with conventional antiviral medicines [4].
Among many islands around the world, the island of Marajó which is part of the Brazilian Amazon, is known to have several cultures formed by indigenous, quilombolas, and mestizo populations that make use of traditional knowledge of plants, which are sometimes used as the only form of therapy in their traditional medicine. The Amazon region also has a very wide plant diversity, being estimated to have from 25 to 30 thousand species of endemic plants, and some species are also associated with the treatment of diseases [5]. In this sense, according to the literature [6], many plants from Marajó island are frequently used for the treatment of diseases, and could be a source of new specific bioactive compounds. This can be applied to expand promising studies.
Based on this, we highlight the importance of searching for new natural sources with antiviral potential, as they can be an alternative to high-cost synthetic drugs with undesirable side effects, in addition to facilitating access to the population. Therefore, we describe a brief narrative review of the main plants inserted in the ethnomedicinal use of Marajó island to treat a lot of diseases, which are directly or indirectly associated with viral agents.
2. Data Research Methodology
The present narrative review originated from the empirical knowledge of some authors of this research and the daily coexistence with the ethnomedical use of plants from the Marajó Island. Posteriorly, the pharmacological and botanical correspondence with the species and its reported therapeutic indication were conformed to specific search descriptors terms in Scopus, Web of Science, Science Direct, Scielo, PubMed, and Google Scholar, as well as the patent offices in Brazil (INPI), United States (USPTO), Europe (EPO) and World Intellectual Property Organization (WIPO). The main keywords of the search were “Marajó”, “antiviral”, “medicinal herbs”, “herbal medicines”, “medicinal plants”, and “traditional medicine”. We emphasize that, in addition to these terms, the names of the species of interest were used after filtering the twelve plants reported in this study.
3. Main Vectors of Diseases Caused by Pathogenic Viruses
The most emerging viruses are zoonotic, which means that they can be transmitted from animals to humans, especially from mammals of the orders Chiroptera, Rodentia, Primates, and Carnivores, as they are hosts to a large diversity of viruses (see Figure 1). For instance, the literature investigated bats as the main vectors responsible for the most zoonotic viral infections. However, the total number of viruses identified in rodents is higher than that in bats [7]. In any case, whenever a virus jumps from animal to human, society is at serious risk.
At present, the world is on alert to the emergence of viruses that are dangerous to public health and have the potential to begin a new pandemic. However, most zoonotic viruses transmitted from animals to humans are not easily transmitted between humans. In this sense, we can have a new problem: humans as new hosts [7].
In Brazil, other important vectors are mosquitoes and ticks, which transmit arbovirus to vertebrates, and are known as arthropod-borne viruses. Arthropods that facilitate efficient virus transmission between susceptible hosts are called vectors. Several arboviruses that are pathogenic to humans, such as the yellow fever virus (YFV), the Chikungunya virus (CHIKV), and the Zika virus (ZIKV), share the same vector, Aedes aegypti mosquito, which are abundant in tropical and subtropical regions [7].
4. The Main Antiviral Plants Used to Treat Viral Diseases in Marajó Island
Many factors motivated the search for new antiviral agents from medicinal plants. From these, we highlight the biggest limitations to the effectiveness of the drugs that are currently available on the market and, although there are several options for antiviral drugs with application in several existing viruses, many of them remain intractable with these drugs. In addition, many synthetic drugs can cause viral resistance and latency. In this sense, the knowledge and wisdom of the natives regarding medicinal plants continues to be a source for the discovery of new molecules with the potential for use as new or complementary antivirals in the treatment of diseases caused by viruses [8].
In the infield of research in the ethnopharmacological area on Marajó, we found reports of plants that have met the immediate needs of communities in this area. In this sense, interest in the diversity of the flora of the Marajó region is not recent, and has led to studies of prospective bioactive compounds from medicinal plants [9] with activity against viruses (Figure 2), such as those caused by Human Immunodeficiency Virus (HIV), Herpes Simplex Virus types 1 and 2 (HSV-1,2), Hepatitis A and B Virus (HAV/HBV), Poliovirus, influenza, and SARS-CoV-2. The influence of many people (Europeans, Africans, etc.), and the exchange of knowledge between such people, continues to reverberate, as can be seen through popular traditions of using medicinal plants [9].
In Table 1, we listed some plants used in Marajó to treat diseases caused by viruses. This was narrated by researchers from this group, who are also natives of the region (authors: P.W.P.G., E.G., and A.M.). In other places of the world, these plants are empirically used for other purposes. We also emphasize that all species have vernacular names, as well as an empirical therapeutic indication. As a complement to this, our group established scientific attributions for in vitro action against viruses already reported in the literature.
Table 1.
Species | Occurrence * | Native Name in Marajó | Part of Plant | Use and Indication | |
---|---|---|---|---|---|
Continent | Region | ||||
Alpiniazerumbet L. | Southern America | Brazil | Vindicá | L, B | Infusion used to treat common viruses |
Bixa Orellana L. | Europe, Southern America | Northern europe, Brazil | Urucum | L | Infusion used to treat flu |
Citrus limon | Southern America | Brazil | Limãozinho | JF | Juice used to treat flu |
Citrus limonum Risso | Southern America | Brazil | Limoeiro | BF | Infusion used to eliminate secretion from the lungs |
Dysphania ambrosioides (L.) | Europe, Southern America | Northern europe, Brazil | Mastruz | L | Juice is used to eliminate secretion from the lungs in viral infections |
Libidibia ferrea (Mart. ex Tul.) L.P.Queiroz | Southern America | Brazil | Jucá | S | Infusion used to treat flu |
Ocimum gratissimum L. | Southern America | Brazil | Alfavacão | L | Tea used to treat flu and cough |
Plectranthus amboinicus (Lour.) Spreng | South Africa, Southern America | Kenya, Angola, Mozambique, Swaziland, northern Natal, Brazil | Hortelã-Grande | L | Tea used to treat inflammation and sore throat |
Spondias mombin L. | Southern America | Brazil | Taperebazeiro | L, B | Infusion used against herpes virus |
Note: L: Leaves; B: Bark; BF: Bark of Fruit; S: Seeds; JF: Juice of Fruit; O: Oil; * http://www.worldfloraonline.org/ (accessed on 15 January 2022).
5. Antiviral Compounds of Medicinal Plants from Marajó
Plants in general naturally have defense mechanisms against microorganisms, especially viruses, which are low-molecular-weight secondary metabolites with a level of toxicity. This factor can explain why such plants have been used therapeutically for viral diseases. Based on a metric review of the literature, Table 2 summarizes the main compounds involved in the antiviral activity of the medicinal plants from Marajo.
Table 2.
Medicinal Plant | Classes Chemical | Assignment Viral | Antiviral Agents | Methods | Action Mechanism | IC50 (µg/mL) | References |
---|---|---|---|---|---|---|---|
Alpinia zerumbet L. | Aromatic heterocycles | HIV-1 | 5,6-Dehidrokavaina (DK) | Multiple integration assay | Inhibition HIV-1 integrase and Neuraminidase Activity | 4.4 μg/mL | [11] |
Dihydro-5,6-dehydrokawain (DDK) | 3.6 μg/mL | ||||||
Bixa orellana L. | Polyphenols | Influenza virus and hepatitis B virus |
procyanidin B2 | CPE inhibition assay | Blockage of viral binding to the cell receptors | 50.85–56.02 μg/mL | [14,15,16] |
lutein | ELISA assay | Inhibition of HBV transcription | 40 μg/mL | ||||
Citrus limon | Terpenes | Hepatitis A virus (HAV) | Limonene, β-pinene, andγ-terpinene Limonexic acid |
Reed and Muench method | Reducing HAV infectivity | 2.84 log TCID50/mL | [17,18] |
Citrus limonum Risso | Flavonoids | Hepatitis A Virus (HAV) | procyanidin B2 | Reed and Muench method | The slight reduction in virus infectivity | 2.84 log TCID50/mL | [17] |
Dysphania ambrosioides( L.) | Flavonoids | SARS-CoV-2 | rutin and nicotiflorin | 3CLpro and RdRp | Molecular docking with 3CLpro (main protease (Mpro)) | in silico | [19,20,21,22] |
Libidibia ferrea (Mart. ex Tul.) L.P.Queiroz | Polysaccharide | HSV-1 | Sulfated polysaccharide | Plaque reduction assay | Antiviral activity by its ability to prevent viral replication | 405 μg/mL | [23] |
Poliovirus (PV) | 1.25-10 μg/mL | ||||||
Ocimum gratissimum L. | Terpenes and Alkaloid | HSV-1,2 | Eugenol | Plaque-based assays (PFU) method | Inhibition of virus replication | 16.2, and 250 µg/mL | [24,25] |
HIV-1,2 | Thymol, and ursolic acidPheophytin-a | Direct destruction of the virion | 7 µM | ||||
Plectranthus amboinicus (Lour.) Spreng | Flavonoids | HSV-1 | Flavonoids | cleavage of peptide substrate | HIV-1 protease inhibitor | 100 µg/mL | [26] |
Spondias mombin L. | Flavonoids and phenolic acids |
HSV-1 | tannin-rich fraction |
Vero E6 cells | Glycoproteins gB and gD of HSV-1 surface | 17.35 µg/mL | [27] |
geraniin | 20.40 µg/mL |
5.1. Alpinia zerumbet L.
Alpinia zerumbet L. is a medicinal plant used in many states in the north and northeast of Brazil [10]. In the Amazon, it has the vernacular name of “Vindicá”. More specifically, in Marajó, the leaves are used to prepare tea and baths that empirically help or bring some benefit for the treatment of flu and colds. To corroborate these antiviral reports, aromatic heterocycles of compounds isolated from the leaves and rhizomes of Alpinia zerumbet showed excellent antiviral activity for human immunodeficiency virus type 1 by the mechanism of inhibition HIV-1 integrase and neuraminidase activity [11]. Moreover, extracts from this species containing dehidrokavaina (DK), and dihydro-5,6-dehydrokawain (DDK) showed the same activity (see Figure 2), with IC50 of values of 30 and 188 μg/mL. These data confirm and highlight the antiviral potential of that species, which is well distributed in the Marajó island.
5.2. Bixa Orellana
Another plant with antiviral properties is Bixa Orellana, also named “Urucum”. It is a very common plant in the northern region of Brazil; however it is also present in other countries of South America, such as Peru, Columbia, Ecuador and Mexico [12,13]. Two antiviral compounds have been isolated from this plant: Procyanidin B2 and Lutein. These compounds block the viral binding to the cell receptors for influenza and inhibit the HBV protease. In this sense, B. orellana is a promising source of compounds that could be applied in antiviral therapy [14,15,16].
5.3. Citrus limon
The Citrus limon species is known in the Marajó island as “Limãozinho”. It has many pharmacological properties as well as important natural chemical constituents, including citric acid and ascorbic acid [28]. For some time, the pharmacological properties of this species were associated with the presence of vitamin C. However, recent data confirm the participation of other supporting substances [28], such as Terpenes [18], Limonene, β-pinene, and γ-terpinene, which have been associated with reductions in hepatitis A virus (HAV) infectivity [17] by reducing HAV infectivity (See Table 2). These results reinforce the potential of this species and place it in the window of natural products with antiviral activities.
5.4. Citrus limonum Risso
Citrus limonum Risso is commonly called “Limoeiro” in the Marajó Island [29]. It belongs to the Rutaceae family and has round and acidic fruits called lemon. Tea from the peels of Citrus limonum fruits is used as a natural expectorant, which helps in the treatment of flu and viruses that cause the accumulation of secretions in the lungs. Recently, the literature reviewed the essential oils of Citrus limonum., and reported several therapeutic benefits, including antiviral activity [30]. To corroborate its empirical use in the Marajó, the literature has already highlighted a role that proves its activity as an expectorant agent [31]. Sheppard and Boyd observed that the expectorant property of lemon oil, when inhaled, is mainly due to limonene (see Figure 2). Recent data reported its activity against influenza viruses [32,33], as well as activity against Hepatitis A Virus (HAV), attributed to Proanthocyanidins, by a slight reduction in virus infectivity [17].
5.5. Dysphania ambrosioides
Dysphania ambrosioides, also known as “mastruz”, is widely used in Brazil as a medicinal plant. It has been reported to have beneficial effects against respiratory diseases. The literature [19] carried out a study with a computational approach (in silico), evaluating the potential of the compounds present in this species, and found that such compounds could inhibit the particles involved in the replication of the SARS-CoV-2 virus, responsible for causing SARS-CoV-2. The focus was on the flavonoid and derivative compounds that are present in this species. The results suggest that the substances Rutin and Nicotiflorin, two of the main “mastruz” flavonoids, and their compounds showed promising potential to block 3CLpro and RdRp proteins, and could play a key role in decreasing or inactivating SARS-CoV-2 infection [19,20,21,22]. The study points to Rutin as a possible alternative to low-molecular-weight heparin (LMWH), due to its anticoagulant and anti-inflammatory effects and its potential protection against acute lung injury (ALI). A computational study has its limitations. Therefore, it is necessary to conduct more in-depth studies, in vitro, in vivo, and clinical, to consolidate the use of these flavonoids or other detected substances, such as medicine.
5.6. Libidibia ferrea
Libidibia ferrea has been suggested to inhibit the replication of HSV-1 and PV viruses. One pioneer study [23] reported the antiviral effect of L. ferrea, and the authors evaluated the effect of the sulfated polysaccharide obtained from the aqueous extract of L. ferrea seeds and its antiviral activity, as well as its ability to prevent viral replication, and viral fixation, and its direct effect on viral particles. The sulfated polysaccharide from L. ferrea extract has a polyanionic character, as sulfated polysaccharides are potent inhibitors of HSV binding to host cells competing with viral glycoprotein receptors. Thus, it is assumed that these substances end up solubilizing the virus envelope, which can also cause chemical changes and the inhibition of essential proteins reaching the virus envelope [23]. The same inhibition effect of this sulfated L. ferrea polysaccharide was observed for Poliovirus (PV), and was even stronger in this case, as it interfered in the initial stages of virus replication. Thus, the study shows that this sulfated L. ferrea polysaccharide has potential as an antiviral, and these mechanisms are likely results of the action of the complex compounds in the extract composition, which may all act together to avoid virus replication [23].
5.7. Ocimum gratissimum L.
Plants of the genus Ocimum are widely used in African countries to treat HIV infection. The literature reported that Ocimum gratissimum leaf extract had 90% effective HIV inhibition after 2 h of infection, a better result than that obtained for AZT, a drug used in the treatment of SIDA, under the same conditions [25]. These results were attributed to Eugenol, Thymol, and ursolic acid caused by the inhibition of virus replication, and direct destruction of the virion mechanism. Moreover, a study conducted with Ocimum species reported activity of this species against Herpes Simplex Virus Type-1 (HSV-1) [34]. All pieces of evidence confirm the antiviral potential of O. gratissimum, as well as the antiviral reports by people from Marajó.
5.8. Plectranthus amboinicus
A flavonoid-rich fraction of the Plectranthus amboinicus showed antiviral activity against HIV-1 and the Herpes Simplex Virus type 1 [26]. It was checked for antiviral activity using the cleavage of peptide substrate method. It showed excellent antiviral activity in cell analysis, with IC50 100 µg/mL, and mechanisms of action for inhibiting HIV-1 protease, showing potential for use as an antiviral agent.
5.9. Spondias mombin L.
Spondias mombin L. is a medicinal plant known vernacularly as “taperebazeiro”, which belongs to the Anacardiaceae family and is found in almost all Brazilian territory (except in the South). This species has been reported to have antiviral activity against Herpes Simplex Virus type 1 (HSV-1) [27]. This study demonstrated that a fraction enriched with tannins and mainly geraniin showed promising anti-HSV-1 activity. The replication cycle of HSV is widespread in molecular biology (1. viral adhesion; 2. entry into host cells; 3. genome modification; 4. replication of genetic material; 5. creation of new capsids; 6. propagation of new viral particles). In this sense, data in the literature highlight that the natural products of split S. mombin may have their main effects in the early stages of HSV-1 infection, and show a better immune response when incubated with viral particles (glycoproteins gB and gD of HSV-1 surface). We understand that in vivo and clinical studies in humans are needed to validate the properties reported here. However, we emphasize that these results are unique and reinforce the herbal potential of S. mombin to treat HSV-1 infections.
6. Future Perspectives
Some antiviral plants described here are also found in other regions, and some compounds can be detected in other species. However, the study of plants that are on Marajó island, although some are not native to the island, are fundamental for the inventory of active biological sources available in the region. Furthermore, scientific reports about those species could promote the development of Marajó, as the trade in medicinal plants could alleviate the poverty of the native peoples, and lead to significant independence, albeit small, from synthetic, expensive, and inaccessible medications. Therefore, these plants are promissory and can open prospects for the use of unexplored resources, which could help in the economic and sustainable use of Brazil’s tropical forests.
Based on the experimental designs available in the literature, we suggest a workflow (Figure 3) for the prospective and respective applications of antiviral candidates (e.g., Phenolics, alkaloids, and terpenes) from plants of the Marajó Island. We believe that studies based on this perspective may lead to promising and indispensable therapeutic alternatives. We carefully highlight, that for highly skilled researchers, this experimental design is already known. However, we also hope to instigate young researchers who carry a larger folk knowledge, for it is of paramount importance that the population receives a return on any resources generated from biodiversity. For this, comprehensive research needs to be developed and validated by regulatory agencies, to ensure that the population enjoys any benefits that these studies may generate. Furthermore, we highlight the importance of translating the folk knowledge of native people to the analytical metrics of scientific research, so that studies can be guided by unequivocal interests.
7. Conclusions
This study shows that the Marajó island (Amazon region), has a high diversity of medicinal plants with high antiviral potential, and must be further studied and valorized. It was seen that secondary metabolites from these species have bioactive compounds that can be useful if isolated and synthesized as potential antiviral agents; however, it is expected that such compounds should exhibit greater potency, selectivity, duration of action, bioavailability, and reduced toxicity. It is important to have a base in the traditional and scientific knowledge of the Marajó plants, as the plant kingdom is becoming an important source of new agents with special biological targets. In recent years, the efforts of several researchers have helped to discover and isolate many secondary metabolites from plants that are also found in Marajó island, have potential antiviral action and can be used in therapy against infectious diseases caused by viruses.
Acknowledgments
All authors acknowledge the institutions the Federal University of Pará, Federal Rural University of Amazonia, Pró-Reitoria de Pesquisa e Pós-Graduação (Propesp/UFPA) and SGB Amravati University for supporting research and for the access to didactic materials and scientific papers.
Author Contributions
Conception and design of the study: P.W.P.G. and L.M.; acquisition of data: P.W.P.G., L.M., E.G., A.K., C.B., A.M., S.P., M.R. and C.S.; analysis and/or interpretation of data: P.W.P.G., L.M., A.M., S.P., C.S. and M.S.; Drafting the manuscript: P.W.P.G., L.M., E.G., A.K. and C.B.; revising the manuscript critically for important intellectual content: M.R., C.S. and M.S. All authors have read and agreed to the published version of the manuscript.
Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Process: 141680/2018-0, Modality: Doctoral Scholarship—GD Graduate Program.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
All support data used in this study are available from the authors.
Conflicts of Interest
We declare no current or potential conflict of interest related to this article.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Mishra S., Pandey A., Manvati S. Coumarin: An emerging antiviral agent. Heliyon. 2020;6:e03217. doi: 10.1016/j.heliyon.2020.e03217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Liu C., Zhou Q., Li Y., Garner L.V., Watkins S.P., Carter L.J., Smoot J., Gregg A.C., Daniels A.D., Jervey S., et al. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases. ACS Cent. Sci. 2020;6:315–331. doi: 10.1021/acscentsci.0c00272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Chattopadhyay D. Role and scope of ethnomedical plants in the development of antivirals. Pharmacologyonline. 2006;3:64–72. [Google Scholar]
- 4.Maryam M., Te K.K., Wong F.C., Chai T.T., Low G.K.K., Gan S.C., Chee H.Y. Antiviral activity of traditional Chinese medicinal plants Dryopteris crassirhizoma and Morus alba against dengue virus. J. Integr. Agric. 2020;19:1085–1096. doi: 10.1016/S2095-3119(19)62820-0. [DOI] [Google Scholar]
- 5.Pedrollo C.T., Kinupp V.F., Shepard G., Heinrich M. Medicinal Plants at Rio Jauaperi, Brazilian Amazon: Ethnobotanical Survey and Environmental Conservation. [(accessed on 20 January 2022)]. Available online: https://reader.elsevier.com/reader/sd/pii/S0378874116301696?token=D504E2452034E7AC5CEE858FB49534EFC37C1F90F2654F0DD575E5CEA955D7A2D873350A9B77375198B7736F3E20EC3F&originRegion=us-east-1&originCreation=20220120202522. [DOI] [PubMed]
- 6.Divya M., Vijayakumar S., Chen J., Vaseeharan B., Durán-Lara E.F. South Indian medicinal plants can combat deadly viruses along with COVID-19?—A review. Microb. Pathog. 2020;148:104277. doi: 10.1016/j.micpath.2020.104277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Artika I.M., Wiyatno A., Ma’Roef C.N. Pathogenic viruses: Molecular detection and characterization. Infect. Genet. Evol. 2020;81:104215. doi: 10.1016/j.meegid.2020.104215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Neto E.M.C., Resende J.J. A percepção de animais como “insetos” e sua utilização como recursos medicinais na cidade de Feira de Santana, Estado da Bahia, Brasil. Acta Sci. Biol. Sci. 2004;26:143–149. doi: 10.4025/actascibiolsci.v26i2.1612. [DOI] [Google Scholar]
- 9.Monteiro M.V.B., Rodrigues S.T., Vasconcelos A.L.F. Plantas medicinais utilizadas na medicina etnoveterinária praticada na ilha do Marajó. Embrapa Amaz. Orient.-Doc. 2012;380:1–33. [Google Scholar]
- 10.Azevedo M.V.D.M.P.D.S., Lins S.R.D.O. Aplicações Terapêuticas da Alpinia Zerumbet (Colônia) Baseado na Medicina Tradicional: uma Revisão Narrativa (2010–2020)/Therapeutic Applications of the Alpinia Zerumbet (Colônia) Based on Traditional Medicine: A Narrative Review (2010–2020) Braz. J. Dev. 2020;6:84222–84242. doi: 10.34117/bjdv6n11-001. [DOI] [Google Scholar]
- 11.Upadhyay A., Chompoo J., Kishimoto W., Makise T., Tawata S. HIV-1 Integrase and Neuraminidase Inhibitors from Alpinia zerumbet. J. Agric. Food Chem. 2011;59:2857–2862. doi: 10.1021/jf104813k. [DOI] [PubMed] [Google Scholar]
- 12.Gonçalves M.L.L., da Mota A.C.C., Deana A.M., Cavalcante L.A.D.S., Horliana A.C.R.T., Pavani C., Motta L.J., Fernandes K.P.S., Mesquita-Ferrari R.A., da Silva D.F.T., et al. Antimicrobial photodynamic therapy with Bixa orellana extract and blue LED in the reduction of halitosis—A randomized, controlled clinical trial. Photodiagn. Photodyn. Ther. 2020;30:101751. doi: 10.1016/j.pdpdt.2020.101751. [DOI] [PubMed] [Google Scholar]
- 13.Kar B., Chandar B., Rachana S.S., Bhattacharya H., Bhattacharya D. Antibacterial and genotoxic activity of Bixa orellana, a folk medicine and food supplement against multidrug resistant clinical isolates. J. Herb. Med. 2021;32:100502. doi: 10.1016/j.hermed.2021.100502. [DOI] [Google Scholar]
- 14.Nascimento Moraes Neto R.N.M., Guedes Coutinho G., de Oliveira Rezende A., de Brito Pontes D., Larissa Pinheiro Soares Ferreira R., de Araújo Morais D., Pontes Albuquerque R., Gonçalves Lima-Neto L., Cláudio Nascimento da Silva L., Quintino da Rocha C., et al. Compounds isolated from Bixa orellana: Evidence-based advances to treat infectious diseases. Rev. Colomb. Cienc. Químico-Farm. 2020;49:581–601. doi: 10.15446/RCCIQUIFA.V49N3.91247. [DOI] [Google Scholar]
- 15.Yang Z.-F., Bai L.-P., Huang W.-B., Li X.-Z., Zhao S.-S., Zhong N.-S., Jiang Z.-H. Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure–activity relationship analysis. Fitoterapia. 2014;93:47–53. doi: 10.1016/j.fitote.2013.12.011. [DOI] [PubMed] [Google Scholar]
- 16.Pang R., Tao J.-Y., Zhang S.-L., Zhao L., Yue X., Wang Y.-F., Ye P., Dong J.-H., Zhu Y., Wu J.-G. In vitro antiviral activity of lutein against hepatitis B virus. Phytother. Res. 2010;24:1627–1630. doi: 10.1002/ptr.3155. [DOI] [PubMed] [Google Scholar]
- 17.Battistini R., Rossini I., Ercolini C., Goria M., Callipo M.R., Maurella C., Pavoni E., Serracca L. Antiviral Activity of Essential Oils against Hepatitis A Virus in Soft Fruits. Food Environ. Virol. 2019;11:90–95. doi: 10.1007/s12560-019-09367-3. [DOI] [PubMed] [Google Scholar]
- 18.Shi Y.-S., Zhang Y., Li H.-T., Wu C.-H., El-Seedi H.R., Ye W.-K., Wang Z.-W., Li C.-B., Zhang X.-F., Kai G.-Y. Limonoids from Citrus: Chemistry, anti-tumor potential, and other bioactivities. J. Funct. Foods. 2020;75:104213. doi: 10.1016/j.jff.2020.104213. [DOI] [Google Scholar]
- 19.Da Silva F.M.A., Da Silva K.P.A., De Oliveira L.P.M., Costa E.V., Koolen H.H., Pinheiro M.L.B., De Souza A.Q.L., De Souza A.D.L. Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) Mem. Inst. Oswaldo Cruz. 2020;115:1–8. doi: 10.1590/0074-02760200207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X., et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020;10:766–788. doi: 10.1016/j.apsb.2020.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Francis D., Variyar E.J. Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro. J. Biomol. Struct. Dyn. 2020;40:325–336. doi: 10.1080/07391102.2020.1813200/SUPPL_FILE/TBSD_A_1813200_SM4421.PDF. [DOI] [PubMed] [Google Scholar]
- 22.Ganeshpurkar A., Saluja A.K. The Pharmacological Potential of Rutin. Saudi Pharm. J. 2017;25:149–164. doi: 10.1016/j.jsps.2016.04.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lopes N., Faccin-Galhardi L.C., Espada S.F., Pacheco A.C., Ricardo N., Linhares R.E.C., Nozawa C. Sulfated polysaccharide of Caesalpinia ferrea inhibits herpes simplex virus and poliovirus. Int. J. Biol. Macromol. 2013;60:93–99. doi: 10.1016/j.ijbiomac.2013.05.015. [DOI] [PubMed] [Google Scholar]
- 24.Tshilanda D.D., Ngoyi E.M., Kabengele C.N., Matondo A., Bongo G.N., Inkoto C.L., Mbadiko C.M., Gbolo B.Z., Lengbiye E.M., Kilembe J.T., et al. Ocimum Species as Potential Bioresources against COVID-19: A Review of Their Phytochemistry and Antiviral Activity. Int. J. Pathog. Res. 2020;5:42–54. doi: 10.9734/ijpr/2020/v5i430143. [DOI] [Google Scholar]
- 25.Ayisi N.K., Nyadedzor C. Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections. Antivir. Res. 2003;58:25–33. doi: 10.1016/S0166-3542(02)00166-3. [DOI] [PubMed] [Google Scholar]
- 26.Thayil S., Thyagarajan S.P. PA-9: A Flavonoid Extracted from Plectranthus amboinicus Inhibits HIV-1 Protease. Int. J. Pharmacogn. Phytochem. Res. 2016;8:1020–1024. [Google Scholar]
- 27.Siqueira E.M.D.S., Lima T.L.C., Boff L., Lima S.G.M., Lourenço E.M.G., Ferreira É.G., Barbosa E.G., Machado P., Farias K.J.S., Ferreira L.D.S., et al. Antiviral Potential of Spondias mombin L. Leaves Extract Against Herpes Simplex Virus Type-1 Replication Using In Vitro and In Silico Approaches. Planta Med. 2020;86:505–515. doi: 10.1055/a-1135-9066. [DOI] [PubMed] [Google Scholar]
- 28.Del Río J., Fuster M., Gómez P., Porras I., García-Lidón A., Ortuño A. Citrus limon: A source of flavonoids of pharmaceutical interest. Food Chem. 2004;84:457–461. doi: 10.1016/S0308-8146(03)00272-3. [DOI] [Google Scholar]
- 29.De Souza R.C., Modesto S.P.B., Maués K.M.G., Dos Santos J.C., Farias A.N., Biancalana A., Biancalana F.S.C. Avaliação da ocorrência de fungos demáceos em espinhos de limoeiro-taiti (citrus latifólia tanaka) no município de Soure-Pa/Evaluation of the occurrence of demaceous fungus in spines of lemon-taiti (citrus latifólia tanaka) in Soure-Pa municipality. Braz. J. Health Rev. 2020;3:14894–14910. doi: 10.34119/bjhrv3n5-280. [DOI] [Google Scholar]
- 30.Prall S., Bowles E.J., Bennett K., Cooke C.G., Agnew T., Steel A., Hausser T. Effects of essential oils on symptoms and course (duration and severity) of viral respiratory infections in humans: A rapid review. Adv. Integr. Med. 2020;7:218–221. doi: 10.1016/j.aimed.2020.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sheppard E.P., Boyd E.M. Lemon oil as an expectorant inhalant. Pharmacol. Res. Commun. 1970;2:1–16. doi: 10.1016/S0031-6989(70)80027-3. [DOI] [Google Scholar]
- 32.Osong Public Health and Research Perspectives. Osong Public Health Res. Perspect. 2012;3:62. doi: 10.1016/j.phrp.2012.03.003. [DOI] [Google Scholar]
- 33.Gumisiriza H., Birungi G., Olet E.A., Sesaazi C.D. Medicinal plant species used by local communities around Queen Elizabeth National Park, Maramagambo Central Forest Reserve and Ihimbo Central Forest Reserve, South western Uganda. J. Ethnopharmacol. 2019;239:111926. doi: 10.1016/j.jep.2019.111926. [DOI] [PubMed] [Google Scholar]
- 34.Moura-Costa G.F., Nocchi S.R., Ceole L.F., de Mello J.C.P., Nakamura C.V., Filho B.P.D., Temponi L.G., Ueda-Nakamura T. Antimicrobial activity of plants used as medicinals on an indigenous reserve in Rio das Cobras, Paraná, Brazil. J. Ethnopharmacol. 2012;143:631–638. doi: 10.1016/j.jep.2012.07.016. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All support data used in this study are available from the authors.